Sulpiride
Back to searchMolecule Structure
Scientific Name
Sulpiride
Description of the Drug
Sulpiride is a selective D2 dopamine receptor antagonist indicated to treat chronic and acute schizophrenia.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00391
http://www.drugbank.ca/drugs/DB00391
Brand Name(s)
Dogmatyl, Dolmatil
Company Owner(s)
Not Available
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Dopamine D2 receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL217 |
Clinical Trial(s)
Unichem Links
| Atlas | sulpiride | |
| SureChEMBL | SCHEMBL8421 | |
| PharmGKB | PA164745485 | |
| Human Metabolome Database | HMDB0014535 | |
| DrugBank | DB00391 | |
| PubChem: Thomson Pharma | 14802423 | |
| PubChem | 5355 | |
| Mcule | MCULE-7506797476 | |
| NMRShiftDB | 20037386 | |
| LINCS | LSM-5080 | |
| Nikkaji | J3.446K | |
| BindingDB | 11638 | |
| EPA CompTox Dashboard | DTXSID1042574 | |
| DrugCentral | 2537 | |
| Brenda | 75628 | 3567 |
| ChemicalBook | CB4141314 | |
| Guide to Pharmacology | 5501 | |
| rxnorm | SULPIRIDE | |
| ChEBI | 32168 |
